Puerarin blocks the aging phenotype in human dermal fibroblasts

Area of Science:

• Dermatology
• Cell Biology
• Aging Research

Background:

• Dermal fibroblast aging leads to skin functional decline.
• Fibroblasts are crucial for maintaining skin homeostasis.
• Aging affects fibroblast interaction with the epidermis and extracellular matrix.

Purpose of the Study:

• To investigate the anti-aging effects of puerarin on human dermal fibroblasts.
• To determine if puerarin can prevent or reverse fibroblast aging phenotypes.
• To explore the mechanism underlying puerarin's action.

Main Methods:

• Used low-passage (young) and high-passage (senescent) human dermal fibroblasts (NHDFs).
• Treated senescent NHDFs with puerarin.
• Assessed cell proliferation, senescence-associated beta-galactosidase activity.
• Measured levels of alpha-smooth muscle actin (SMA) and calponin 1 (CNN1).
• Utilized fulvestrant (estrogen receptor antagonist) to investigate the role of estrogen receptors.

Main Results:

• Puerarin increased cell proliferation in high-passage NHDFs.
• Puerarin decreased senescence-associated beta-galactosidase-positive cells.
• Puerarin reduced the number of myofibroblasts (SMA-positive) and CNN1 expression.
• Fulvestrant blocked puerarin's effect on SMA and CNN1, suggesting estrogen receptor involvement.

Conclusions:

• Puerarin demonstrates potential in preventing and reversing dermal fibroblast aging.
• The anti-aging effects of puerarin may involve estrogen receptor signaling.
• Puerarin could be a beneficial component in functional foods for skin health.